Editorial: tenofovir alafenamide fumarate-a new silver bullet to prevent mother-to-child transmission of hepatitis B virus
- PMID: 33205879
- DOI: 10.1111/apt.16090
Editorial: tenofovir alafenamide fumarate-a new silver bullet to prevent mother-to-child transmission of hepatitis B virus
Comment in
-
Editorial: tenofovir alafenamide fumarate-a new bullet to prevent mother-to-child transmission of hepatitis B virus. Authors' reply.Aliment Pharmacol Ther. 2020 Dec;52(11-12):1746-1747. doi: 10.1111/apt.16101. Aliment Pharmacol Ther. 2020. PMID: 33205865 No abstract available.
Comment on
-
Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.Aliment Pharmacol Ther. 2020 Oct;52(8):1377-1386. doi: 10.1111/apt.16043. Epub 2020 Aug 27. Aliment Pharmacol Ther. 2020. PMID: 32852100
References
REFERENCES
-
- Razavi-Shearer D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383-403.
-
- Terrault N, Bzowej N, Chang K, Hwang J, Jonas M, Murad M. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261-283.
-
- Lampertico P, Agarwal K, Berg T, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398.
-
- Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98.
-
- World Health Organization. Prevention of mother to child transmission of hepatitis B virus: Guidelines on antiviral prophylaxis in pregnancy. July 2020. https://www.who.int/publications/i/item/978-92-4-000270-8. Accessed August 24, 2020